News

Posted: 2015-12-03

TORONTO (DECEMBER 3, 2015) – Bladder Cancer Canada (BCC) has awarded its inaugural $50,000 Bladder Cancer Canada Research Grant to Dr. Alan So along with Co‐Investigator Dr. Claudia Chavez‐Munoz. They will be studying 3D Bioprinted Tissues: Building a novel platform for bladder cancer.

Bioprinting has the potential to revolutionise medical research well beyond what seemed possible even 20 years ago.

Posted: 2015-10-13

Scientists at the University of British Columbia, Vancouver Coastal Health and the BC Cancer Agency have discovered a protein from malaria that could one day help stop cancer in its tracks.

This new approach, which halted the growth of various tumours in mice, was based on a discovery by collaborators at the University of Copenhagen. While exploring why pregnant women are particularly susceptible to malaria, they found that the mosquito-borne parasite produces a protein that binds to a particular type of sugar molecule in the placenta.

Posted: 2015-07-30

Drs. Akamatsu, Wyatt, Gleave and Collins and their team at the VPC have published the result of their ground-breaking work identifying a gene called PEG10 as a novel and highly-specific therapeutic target for neuroendocrine prostate cancer (NEPC) ("The placental gene PEG10 promotes progression of neuroendocrine prostate cancer", Cell Reports, published online).

Posted: 2015-06-19

The Mr. Lube Tournament for Life 2015 golf fundraiser was held on June 15. The event raised $554,000 which is the largest amount raised in the tournament's 19 year history. The UBC and VGH Hospital Foundation and the Vancovuer Prostate Centre would like to thank the generous donors, volunteers and sponsors who made this event so successful.

You can read more about the event and watch a 4.5 minute video of one man's storyhere.

Posted: 2015-06-12

Dr. S. Larry Goldenberg was presented with the Doctors of BC Silver Medal of Service award at the Doctors of BC Annual General Meeting on June 6, 2015.  Established in 1986, this award confers the Association’s highest honor. 

Posted: 2015-03-24

A breakthrough study published in Clinical Cancer Research describes a minimally invasive method for interrogating mechanisms of therapeutic resistance in metastatic castration-resistant prostate cancer.

Posted: 2015-03-12

The Future of Prostate Cancer Care: How Dr. Kim Chi translates research into care is the cover story of the Spring 2015 issue of BC Cancer Foundation's Partners in Discovery Magazine.  

Dr. Chi holds the positions of Associate Director, Clinical Research and a Senior Research Scientist at the Vancouver Prostate Centre, and Medical Oncologist, Medical Director - Clinical Trials Unit and Chair - Genitourinary Systemic Group at the BC Cancer Agency.

Posted: 2015-01-01

A recent preliminary retrospective study of patients on active surveillance has demonstrated a technique to enhance the identification of patients requiring definitive treatment.

Posted: 2014-11-19

November 18, 2014 - Prostate Cancer Canada has awarded a third Translation Acceleration Grant under their program TAG2: Novel Therapeutics for Advanced Disease. This funding is for groups studying novel therapeutics and treatment options for metastatic and castrate-resistant prostate cancer, for projects aimed at eliminating advanced disease from affected men.

Posted: 2014-11-18

The latest issue of Vancouver Coastal Health Research Institute News includes a discussion with Dr. Ralph Buttyan on his Prostate Cancer Canada - Movember funded team research program. The article "How Movember’s moustaches are taking prostate cancer down" is available here.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.